NCT02293694View on ClinicalTrials.gov

Sayana® Press Self-injection Study in Malawi

NACompletedINTERVENTIONAL
Enrollment

735

Participants

Timeline

Start Date

September 17, 2015

Primary Completion Date

January 27, 2017

Study Completion Date

August 30, 2017

Conditions
Contraception
Interventions
DRUG

Sayana Press

Sayana® Press is a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in a prefilled, auto-disabled injection system called Uniject

Trial Locations (1)

Unknown

College of Medicine, Department of Community Health, Blantyre

All Listed Sponsors
lead

FHI 360

OTHER

NCT02293694 - Sayana® Press Self-injection Study in Malawi | Biotech Hunter | Biotech Hunter